Fish Oil + Acidifying AgentsModerate
Prolonged bleeding time reported in patients taking antiplatelet agents with oral omega-3 fatty acids. Periodic monitoring of bleeding time recommended.
Source: NLP:fish oil
Fish Oil Interactions
Brand names: Omegaven
Route: Intravenous
Contraindications
4 CONTRAINDICATIONS Use of Omegaven is contraindicated in patients with: • Known hypersensitivity to fish or egg protein or to any of the active ingredients or excipients [see Warnings and Precautions ( 5.2 )]. • Severe hemorrhagic disorders due to a potential effect on platelet aggregation. • Severe disorders of lipid metabolism characterized by hypertriglyceridemia (serum triglyceride concentrations greater than 1,000 mg/dL) [see Warnings and Precautions ( 5.6 )]. • Known hypersensitivity to fish or egg protein or to any of the active ingredients or excipients. ( 4 ) • Severe hemorrhagic disorders. ( 4 ) • Severe disorders of lipid metabolism characterized by hypertriglyceridemia (with serum triglycerides greater than 1,000 mg/dL). ( 4 , 5.6 )
Pregnancy & Breastfeeding
8.1 Pregnancy Risk Summary There are no available data on Omegaven use in pregnant women to establish a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies have not been conducted with fish oil triglycerides. The estimated background risk of major birth defects and miscarriage in the indicated population is unknown. All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the US general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20%, respectively.
2 interactions on record
Fish Oil + Oral AnticoagulantsModerate
Prolonged bleeding time reported in patients taking anticoagulants with oral omega-3 fatty acids. Periodic monitoring of bleeding time recommended.
Source: NLP:fish oil